Marc Dunoyer
Directeur Général chez ALEXION PHARMACEUTICALS, INC.
Relations actives
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Pascal Soriot | M | 64 |
AstraZeneca UK Ltd.
 AstraZeneca UK Ltd. Miscellaneous Commercial ServicesCommercial Services AstraZeneca UK Ltd. manufactures pharmaceutical products. Its products are used to treat cardiovascular diseases, diabetes, and gastrointestinal infections. The company was founded on November 26, 1998 and is headquartered in London, the United Kingdom.
Acerta Pharma BV
 Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands. | 12 ans |
| Bobby Gaspar | M | 60 |
Orchard Therapeutics (Europe) Ltd.
 Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Orchard Therapeutics (Europe) Ltd. researches on transformative gene therapies. Its services include stem cell technology, gene therapy, eradicating orphan diseases, and paediatric diseases. The company was founded by Andrea Spezzi and Nicolas Koebel on September 1, 2015 and is headquartered in London, the United Kingdom. | 9 ans |
| André Choulika | M | 59 | 25 ans | |
| David Sourdive | M | 57 | 25 ans | |
| Charles Rowland | M | 65 |
Orchard Therapeutics (Europe) Ltd.
Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Orchard Therapeutics (Europe) Ltd. researches on transformative gene therapies. Its services include stem cell technology, gene therapy, eradicating orphan diseases, and paediatric diseases. The company was founded by Andrea Spezzi and Nicolas Koebel on September 1, 2015 and is headquartered in London, the United Kingdom. | 6 ans |
| Alicia Secor | F | 62 |
Orchard Therapeutics (Europe) Ltd.
Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Orchard Therapeutics (Europe) Ltd. researches on transformative gene therapies. Its services include stem cell technology, gene therapy, eradicating orphan diseases, and paediatric diseases. The company was founded by Andrea Spezzi and Nicolas Koebel on September 1, 2015 and is headquartered in London, the United Kingdom. | 6 ans |
| Emma Walmsley | F | 55 | 14 ans | |
| Joanne Beck | M | 63 |
Orchard Therapeutics (Europe) Ltd.
Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Orchard Therapeutics (Europe) Ltd. researches on transformative gene therapies. Its services include stem cell technology, gene therapy, eradicating orphan diseases, and paediatric diseases. The company was founded by Andrea Spezzi and Nicolas Koebel on September 1, 2015 and is headquartered in London, the United Kingdom. | 6 ans |
| Jon Ellis | M | 57 |
Orchard Therapeutics (Europe) Ltd.
Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Orchard Therapeutics (Europe) Ltd. researches on transformative gene therapies. Its services include stem cell technology, gene therapy, eradicating orphan diseases, and paediatric diseases. The company was founded by Andrea Spezzi and Nicolas Koebel on September 1, 2015 and is headquartered in London, the United Kingdom. | 6 ans |
| Tjeerd Barf | M | - |
Acerta Pharma BV
Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands. | - |
| Jeffrey Pott | M | - | 29 ans | |
| Michel Demaré | M | 67 | 5 ans | |
| Phil Thomson | M | - | 13 ans | |
| James Geraghty | M | 69 |
Orchard Therapeutics (Europe) Ltd.
Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Orchard Therapeutics (Europe) Ltd. researches on transformative gene therapies. Its services include stem cell technology, gene therapy, eradicating orphan diseases, and paediatric diseases. The company was founded by Andrea Spezzi and Nicolas Koebel on September 1, 2015 and is headquartered in London, the United Kingdom. | 6 ans |
| Frank Thomas | M | 54 |
Orchard Therapeutics (Europe) Ltd.
Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Orchard Therapeutics (Europe) Ltd. researches on transformative gene therapies. Its services include stem cell technology, gene therapy, eradicating orphan diseases, and paediatric diseases. The company was founded by Andrea Spezzi and Nicolas Koebel on September 1, 2015 and is headquartered in London, the United Kingdom. | 6 ans |
| Simone Song | F | 59 |
Orchard Therapeutics (Europe) Ltd.
Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Orchard Therapeutics (Europe) Ltd. researches on transformative gene therapies. Its services include stem cell technology, gene therapy, eradicating orphan diseases, and paediatric diseases. The company was founded by Andrea Spezzi and Nicolas Koebel on September 1, 2015 and is headquartered in London, the United Kingdom. | 7 ans |
| Rainer Boehm | M | 63 | 7 ans | |
| Pam Cheng | F | 53 | 9 ans | |
| Nazneen Rahman | M | - | 7 ans | |
| Sherilyn McCoy | F | 65 | 7 ans | |
| Aradhana Sarin | M | 50 | 3 ans | |
| Marie-Bleuenn Terrier | F | 42 | 16 ans | |
| Shu Kam Mok | M | 63 | 5 ans | |
| Gianluca Pirozzi | M | 47 | 5 ans | |
| Sean Christie | M | - | 3 ans | |
| Takafumi Horii | M | - |
AstraZeneca KK
 AstraZeneca KK Pharmaceuticals: MajorHealth Technology AstraZeneca KK develops, manufactures and sells prescription drugs. It also conducts medical research. The company was founded on April 11, 1975 and is headquartered in Osaka, Japan. | 2 ans |
| Mark Frattini | M | 58 | 4 ans | |
| Jonathan Thomas Charles Slade | M | 59 |
Astrazeneca Intermediate Holdings Ltd.
 Astrazeneca Intermediate Holdings Ltd. Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca Intermediate Holdings Ltd. operates as a British intermediate holding company through its subsidiaries and researches, manufactures, and markets pharmaceuticals. The company is based in Cambridge, UK. | - |
| Pascal Claude Roland Soriot | - | - |
AstraZeneca UK Ltd.
AstraZeneca UK Ltd. Miscellaneous Commercial ServicesCommercial Services AstraZeneca UK Ltd. manufactures pharmaceutical products. Its products are used to treat cardiovascular diseases, diabetes, and gastrointestinal infections. The company was founded on November 26, 1998 and is headquartered in London, the United Kingdom. | 12 ans |
| Donald Bergstrom | M | 52 | 2 ans | |
| Axel-Sven Malkomes | M | 57 | 2 ans | |
| Allard Kaptein | M | - |
Acerta Pharma BV
Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands. | 12 ans |
| Philip Broadley | M | 63 | 7 ans | |
| Laurent Arthaud | M | 61 | 13 ans | |
| Adrian Charles Noel Kemp | M | 58 |
Astrazeneca Intermediate Holdings Ltd.
Astrazeneca Intermediate Holdings Ltd. Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca Intermediate Holdings Ltd. operates as a British intermediate holding company through its subsidiaries and researches, manufactures, and markets pharmaceuticals. The company is based in Cambridge, UK. | 15 ans |
| Roger Ulrich | M | - |
Acerta Pharma BV
Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands. | 11 ans |
| Pierre Bastid | M | 69 | 13 ans | |
| Stephan Reynier | M | 55 | 13 ans | |
| Deborah DiSanzo | F | 64 | 7 ans | |
| Marcus Wallenberg | M | 68 | 25 ans | |
| Seng Cheng | M | - | 1 ans | |
| Cécile Chartier | M | - | 1 ans | |
| Regina Danielson | M | 60 | - | |
| Ruth Diazaraque | M | - | 1 ans | |
| Pascalyne Wilson | M | - | - | |
| Jean-Pierre Garnier | M | 75 | 4 ans | |
| Christophe Hotermans | M | - | 4 ans | |
| Frannie DeFranco | F | - | 14 ans | |
| Josie Afolabi | F | - | 14 ans | |
| Sarah Marshall | F | - | 10 ans | |
| Piyush Sharma | M | - | 7 ans | |
| Tamar Thompson | F | 50 | 5 ans | |
| Glen Frick | M | 57 | - | |
| Arthur Stril | M | 35 | 6 ans | |
| Nicola Heffron | F | 52 | 1 ans | |
| Morgan Sanford | F | - | - | |
| Kyung Nam-Wortman | F | 54 | 4 ans | |
| Steve Doares | M | - | 4 ans | |
| Frédéric Chéreau | M | 57 | 2 ans | |
| Iskra Reic | F | - | 23 ans | |
| Helen MacPhee | F | 64 | - | |
| Patryk Mikucki | M | 49 | - | |
| Philippe Duchateau | M | 61 | 23 ans | |
| Ruud Dobber | M | - | 27 ans | |
| Margareta Elisabeth Björk | M | 62 | 22 ans | |
| María Cristina de Luna Basagoiti | F | - | 14 ans | |
| Todd Spalding | M | - | - |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Mark Rothera | M | 61 |
Orchard Therapeutics (Europe) Ltd.
Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Orchard Therapeutics (Europe) Ltd. researches on transformative gene therapies. Its services include stem cell technology, gene therapy, eradicating orphan diseases, and paediatric diseases. The company was founded by Andrea Spezzi and Nicolas Koebel on September 1, 2015 and is headquartered in London, the United Kingdom. | 3 ans |
| Simon Lowth | M | 61 | 6 ans | |
| Nicolas Koebel | M | - |
Orchard Therapeutics (Europe) Ltd.
Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Orchard Therapeutics (Europe) Ltd. researches on transformative gene therapies. Its services include stem cell technology, gene therapy, eradicating orphan diseases, and paediatric diseases. The company was founded by Andrea Spezzi and Nicolas Koebel on September 1, 2015 and is headquartered in London, the United Kingdom. | 7 ans |
| Leif Valdemar Johansson | M | 73 | 11 ans | |
| Thomas Mount | M | - | 7 ans | |
| Philippe Fauchet | M | 65 |
GlaxoSmithKline KK
 GlaxoSmithKline KK Household/Personal CareConsumer Non-Durables GlaxoSmithKline KK researches, develops, imports, manufactures and sells toiletry products. The company was founded on August 18, 1928 and is headquartered in Tokyo, Japan | 9 ans |
| Jean-Philippe Courtois | M | 63 | 8 ans | |
| Shriti Vadera | F | 62 | 7 ans | |
| David Smith | M | - | 9 ans | |
| John Curnutte | M | 72 | 5 ans | |
| Ayesha Bharmal | F | - | 5 ans | |
| Menelas Pangalos | M | 57 | 13 ans | |
| Donald Bruce Burlington | M | 75 | 7 ans | |
| Anjali Bansal | F | 53 | 6 ans | |
| Jacques Dumas | M | 58 | 7 ans | |
| Ravi Rao | M | 55 | 7 ans | |
| Jing Ulrich | F | 57 | - | |
| Joseph Peter | M | 61 | - | |
| Briggs Morrison | M | 65 | 3 ans | |
| Judy Lewent | F | 75 | 10 ans | |
| Geneviéve B. Berger | M | 69 | 9 ans | |
| Nancy Rothwell | M | 68 | 9 ans | |
| Lynn Elsenhans | F | 68 | 10 ans | |
| Julian Heslop | M | 70 | 13 ans | |
| Simon Dingemans | M | 61 | 8 ans | |
| Graham Chipchase | M | 61 | 9 ans | |
| John Varley | M | 67 | 9 ans | |
| Stacey Cartwright | F | 60 | 5 ans | |
| Rudolph Markham | M | 78 | 11 ans | |
| Crispin Davis | M | 75 | 10 ans | |
| James Murdoch | M | 50 | 3 ans | |
| H. Culp | M | 60 | 9 ans | |
| Michael Zinda | M | 53 | 16 ans |
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| Royaume-Uni | 64 | 64,00% |
| France | 17 | 17,00% |
| Etats-Unis | 14 | 14,00% |
| Pays-Bas | 4 | 4,00% |
| Japon | 2 | 2,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Marc Dunoyer
- Réseau Personnel
